000			01991 a2200529 4500
005			20250513194926.0
264		0	_c19991130
008			199911s 0 0 eng d
022			_a1079-5642
024	7		_a10.1161/01.atv.19.11.2584 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchwarz, P M
245	0	0	_aPotential functional significance of brain-type and muscle-type nitric oxide synthase I expressed in adventitia and media of rat aorta. _h[electronic resource]
260			_bArteriosclerosis, thrombosis, and vascular biology _cNov 1999
300			_a2584-90 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntisense Elements (Genetics)
650	0	4	_aAorta, Abdominal _xenzymology
650	0	4	_aAorta, Thoracic _xenzymology
650	0	4	_aBlotting, Western
650	0	4	_aBrain _xenzymology
650	0	4	_aCalcium _xpharmacology
650	0	4	_aDNA, Complementary
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Enzymologic
650	0	4	_aImmunoenzyme Techniques
650	0	4	_aMembrane Potentials _xphysiology
650	0	4	_aMuscle, Skeletal _xenzymology
650	0	4	_aMuscle, Smooth, Vascular _xenzymology
650	0	4	_aNitric Oxide Synthase _xanalysis
650	0	4	_aNitric Oxide Synthase Type I
650	0	4	_aNitric Oxide Synthase Type III
650	0	4	_aNitroarginine _xpharmacology
650	0	4	_aNorepinephrine _xpharmacology
650	0	4	_aPotassium Chloride
650	0	4	_aRNA, Messenger _xanalysis
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aTunica Media _xenzymology
650	0	4	_aVasoconstriction _xdrug effects
650	0	4	_aVasoconstrictor Agents _xpharmacology
700	1		_aKleinert, H
700	1		_aFörstermann, U
773	0		_tArteriosclerosis, thrombosis, and vascular biology _gvol. 19 _gno. 11 _gp. 2584-90
856	4	0	_uhttps://doi.org/10.1161/01.atv.19.11.2584 _zAvailable from publisher's website
999			_c10515343 _d10515343